Uterine Tourniquet at Open Myomectomy

December 21, 2014 updated by: Ragıp Atakan Al, Ataturk University

Triple Tourniquet vs. Single Tourniquet at Open Myomectomy to Reduce Blood Loss: A Prospective Randomised Controlled Trials

The aim of study is to compare triple tourniquet vs. single tourniquet to reduce blood loss at open myomectomy.

Study Overview

Detailed Description

Single tourniquet is applied to uterine isthmus to occlude uterine arteries. Triple tourniquet is applied to both infundibulopelvic ligaments and uterine isthmus.

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yakutiye
      • Erzurum, Yakutiye, Turkey, 25240
        • Atatürk Üniversitesi Araştırma Hastanesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 48 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • uterine myoma >12 weeks

Exclusion Criteria:

  • Pedunculated myoma, broad ligament myoma
  • Hb<10.5 g /dl

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Single tourniquet
Single tourniquet is tourniquet applied uterine isthmus to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os.
Active Comparator: Triple tourniquet

Triple tourniquet consist of two tourniquet applied both infundibulopelvic ligaments and one uterine isthmus to occlude the left and right ovarian vessels and to occlude the uterine arteries. For this purpose, a small opening is made in the avascular place of the broad ligament on either side of the uterine isthmus superior to the uterine vessels. A pediatric Foley catheter is threaded through the two holes and tied tightly anteriorly around the cervix at the level of the internal os.

Through the same openings in the broad ligament each side a Foley catheter looped around the infundibulopelvic ligament lateral to the fallopian tube and ovary.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Estimating blood loss at the end of myomectomy
Time Frame: 15 minutes postoperatifly

Surgical blood loss will be estimated by sum of the volume of suction fluid and blood loss quantitated by gravimetric method.

During surgery, if it is possible, irrigation will not be done, surgical sponge and compress will not be used.

  • Suction fluid will be measured at the end of operation and volume of irrigation fluid will be subtracted from total suction volume.
  • Surgical drapes, sponges and towels will be weighted before and just after surgery. The blood loss will be estimated as differences in gram by weighing when 1ml blood supposed as 1 gr.
15 minutes postoperatifly

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A change in hemoglobin
Time Frame: At baseline and 48 hours after surgery
At baseline and 48 hours after surgery
Volume in drains
Time Frame: 7 days
Drain will be removed when discharge drops below 50 ml/day
7 days
The amount of transfusions
Time Frame: 7 Days
Erythrocyte transfusions transfusion will be allowed when haemoglobin dropped below 8 g/dL.
7 Days
Anti-Mullerian Hormone levels variation
Time Frame: 6 weeks
Anti-Mullerian Hormone levels before and 6 months after surgery
6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tourniquet time
Time Frame: 5 minutes after tourniquet removed
5 minutes after tourniquet removed
Peri-operative complications
Time Frame: 6 weeks postoperatively
Including but not limited to fever, pelvic infections, wound infections.
6 weeks postoperatively
Total operation time
Time Frame: 5 minutes post operatively
5 minutes post operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

January 28, 2014

First Submitted That Met QC Criteria

January 28, 2014

First Posted (Estimate)

January 30, 2014

Study Record Updates

Last Update Posted (Estimate)

December 23, 2014

Last Update Submitted That Met QC Criteria

December 21, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myomectomy

Clinical Trials on Single tourniquet

3
Subscribe